Immutep LimitedIMMPNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-16.4%
5Y CAGR+15.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-16.4%/yr
vs +25.7%/yr prior
5Y CAGR
+15.8%/yr
Recent deceleration
Acceleration
-42.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 47.81% |
| 2024 | 44.29% |
| 2023 | -8.13% |
| 2022 | 81.83% |
| 2021 | -15.49% |
| 2020 | 22.93% |
| 2019 | 66.08% |
| 2018 | 32.74% |
| 2017 | 6.60% |
| 2016 | -21.14% |